Tag: APOE

New Study Helps Explain Alzheimer’s Genetic Risk

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Brain Injury, Mental Decline, and the APOE Gene

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

A Genetic Variant Protective Against Alzheimer’s

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

World Alzheimer’s Day

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Genetics and the Risks from Traumatic Brain Injuries

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Studies of Extreme Longevity Extremely Challenging

By David Hinds, Chuong Do, and Shirley Wu In January we wrote about the challenging search for genetic influences on human longevity, touching on two of the most recent studies as examples of how elusive solid findings have been. Because one of these studies was a new version of a paper that was previously ...

Read more

SNPwatch: Large Study Identifies Two More Genetic Variants Associated with Alzheimer’s Disease

Understanding Alzheimer's disease, the most common cause of dementia in people 65 years and older, is of the utmost importance as the population of the United States (and many other nations) becomes increasingly older.  Currently more than five million Americans are thought to have the disease, but by the ...

Read more

SNPwatch: Largest Alzheimer’s Genetic Studies To Date Identify Three New Susceptibility Genes

Despite years of effort and millions of dollars in research funding, only one gene, APOE, has been conclusively associated with Alzheimer's disease risk so far.  But now the results of two of the largest Alzheimer's studies ever provide convincing evidence that three more genes affect risk for the ...

Read more

Return to top